v3.26.1
CONSOLIDATED STATEMENT OF CASH FLOWS
12 Months Ended
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Cash flows from operating activities:    
Net loss $ (15,349,246) $ (7,088,306)
Net loss from discontinued operations (392,731) (300,499)
Net loss from continuing operations (14,956,515) (6,787,807)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities from continuing operations:    
Depreciation and amortization 384,165 432,595
Deferred income tax benefit (684,115)  
Impairment of intangible asset 2,698,975  
Loss on write-off of property and equipment 145,131  
Unrealized gain on change in fair value of warrants classified as a liability (319,630) (9,430,000)
Unrealized loss on change in fair value of warrants classified as a liability-warrant modification   394,000
Transaction costs allocated to warrant liabilities   633,198
Loss on issuance of warrants   1,633,767
Shares issued Spindle earnout   17,112
Stock-based compensation 102,021 572,293
Bad debt expense 6,465  
Change in operating assets and liabilities:    
Accounts receivable (5,613) (115,286)
Inventories 348,623 (118,591)
Prepaid expenses, other current assets and deposits 511,055 (391,687)
Accounts payable and accrued liabilities (516,716) (412,172)
Deferred revenue 43,500 (17,650)
Net cash used in operating activities from continuing operations (12,242,654) (13,590,228)
Cash flows from investing activities:    
Purchase of property and equipment (313,121) (407,904)
Net cash used in investing activities from continuing operations (313,121) (407,904)
Cash flows from financing activities:    
Net proceeds from exercise of warrants 2,508,133 394
Capitalized offering costs (166,341)  
Net proceeds from issuance of common stock and pre-funded warrants 5,712,700 13,398,215
Net cash provided by financing activities from continuing operations 8,054,492 13,398,609
CASH FLOWS FROM DISCONTINUED OPERATIONS    
Cash used in operating activities (276,041) (121,182)
Cash provided by investing activities 21,000 0
Net provided by discontinued operations (255,041) (121,182)
Net increase in cash, cash equivalents and restricted cash (4,756,324) (720,705)
Cash, cash equivalents and restricted cash at beginning of period 7,181,095 7,901,800
Cash, cash equivalents and restricted cash at end of period 2,424,771 7,181,095
Less: cash and cash equivalents of discontinued operations (6,971) (578,732)
Cash, cash equivalents and restricted cash of continuing operations at end of period 2,417,800 6,602,363
Supplemental Disclosures of Cash Flow Information:    
Cash paid during period for income taxes 2,417,800  
Non-cash investing and financing activities:    
Transaction costs included in accounts payable 843,728  
Deemed dividend warrant modifications 54,326,896 233,087
Warrants issued, cashlessly $ 1,314  
Property and equipment acquired and included in accounts payable   $ 3,484